Emerging role of biosimilars: Focus on trastuzumab and metastatic human epidermal growth factor receptor 2-positive breast cancer
Biosimilars are emerging class of medications that are very similar to biologics (in terms of safety and efficacy to the original reference product); but not ealisboa.com the same as generic, originating, or reference drugs.The availability and use of biosimilars in oncology landscape are slowly picking, thereby combating financial burden to cancer